SHEILA GALLEGO: Open Payments
NPI 1841969953 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 66 payments from 12 companies in 2025. Trend: 2023 $868 · 2024 $1,007 · 2025 $1,139
Food & beverage: $1,064Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $324 |
| ABBVIE INC. | 13 | $242 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $146 |
| Amgen Inc. | 4 | $99 |
| UCB, Inc. | 3 | $89 |
| Galderma Laboratories, L.P. | 3 | $51 |
| Incyte Corporation | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Organon LLC | 4 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
Products named: TREMFYA, SKYRIZI, Otezla, Bimzelx, RINVOQ, NEMLUVIO, OPZELURA, COSENTYX.
Industry payments across FL — which companies pay providers there.
